Phase 4 Crohn's Disease Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Crohn's DiseaseUlcerative Colitis
Takeda400 enrolled98 locationsNCT06581328
Recruiting
Phase 4
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Crohn's Disease
Takeda100 enrolled54 locationsNCT06045754
Recruiting
Phase 4
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Crohn DiseaseDisease CrohnModerately to Severely Active Crohn's Disease
Alimentiv Inc.304 enrolled69 locationsNCT06257706
Recruiting
Phase 4
Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Crohn's Disease
Centre Hospitalier Universitaire de Saint Etienne220 enrolled12 locationsNCT06180382
Not Yet Recruiting
Phase 4
Upadacitinib versus Oral Corticosteroid for Induction of Transmural Remission in Moderate to Severe Ulcerative Colitis and Crohn’s Disease Flares - INDUCE
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Mater Misericordiae Ltd80 enrolled1 locationACTRN12625000861459
Recruiting
Phase 4
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Crohn DiseasePerianal Fistula Due to Crohn's DiseaseInfliximab+2 more
Asan Medical Center86 enrolled1 locationNCT06051253
Completed
Phase 4
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease
Crohn's DiseaseCOVID-19Ulcerative Colitis
Dr Ai Tran100 enrolled2 locationsACTRN12621000661875
Not Yet Recruiting
Phase 4
A Prospective Randomised Controlled Trial of Adults with Perianal Fistulising Crohn’s Disease and Optimised Therapeutic Infliximab Levels: PROACTIVE Trial
Perianal fistulising Crohn's Disease
Associate Professor Susan Connor138 enrolled24 locationsACTRN12621000023853
Active
Phase 4
PROxIMO: Efficacy of proactive therapeutic drug monitoring and dose adjustment of infliximab based on point of care testing for inflammatory bowel disease
Crohn's DiseaseUlcerative Colitis
Alfred Health Pharmacy Department80 enrolled1 locationACTRN12616001031459